Compounds > campesterol
Page last updated: 2024-09-05

campesterol and Metabolic Syndrome

campesterol has been researched along with Metabolic Syndrome in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (66.67)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chan, DC; Ng, TW; Ooi, EM; Watts, GF1
Bañuls, C; Bellod, L; Hernández-Mijares, A; Jover, A; Lagarda, MJ; Martínez-Triguero, ML; Rocha, M; Solá, E; Víctor, VM1
De Vuono, S; Lupattelli, G; Mannarino, E1
Barrett, PH; Chan, DC; O'Neill, FH; Redgrave, TG; Thompson, GR; Watts, GF1
Barrett, PH; Chan, DC; O'Neill, FH; Thompson, GR; Watts, GF2

Reviews

1 review(s) available for campesterol and Metabolic Syndrome

ArticleYear
Patterns of cholesterol metabolism: pathophysiological and therapeutic implications for dyslipidemias and the metabolic syndrome.
    Nutrition, metabolism, and cardiovascular diseases : NMCD, 2011, Volume: 21, Issue:9

    Topics: Biomarkers; Cholestanol; Cholesterol; Dyslipidemias; Humans; Lipid Metabolism; Metabolic Syndrome; Phytosterols; Sitosterols

2011

Trials

3 trial(s) available for campesterol and Metabolic Syndrome

ArticleYear
Low intestinal cholesterol absorption is associated with a reduced efficacy of phytosterol esters as hypolipemic agents in patients with metabolic syndrome.
    Clinical nutrition (Edinburgh, Scotland), 2011, Volume: 30, Issue:5

    Topics: Adult; Anticholesteremic Agents; Cardiovascular Diseases; Cholesterol; Cholesterol, Dietary; Dietary Supplements; Female; Humans; Hypercholesterolemia; Hypolipidemic Agents; Intestinal Absorption; Lipoproteins; Male; Metabolic Syndrome; Middle Aged; Phytosterols; Risk Factors; Severity of Illness Index; Sitosterols; Spain

2011
Relationships between cholesterol homoeostasis and triacylglycerol-rich lipoprotein remnant metabolism in the metabolic syndrome.
    Clinical science (London, England : 1979), 2003, Volume: 104, Issue:4

    Topics: Apolipoprotein B-48; Apolipoproteins B; Biomarkers; Breath Tests; Case-Control Studies; Cholesterol; Humans; Linear Models; Lipoproteins; Male; Metabolic Syndrome; Middle Aged; Phytosterols; Triglycerides

2003
Effect of a statin on hepatic apolipoprotein B-100 secretion and plasma campesterol levels in the metabolic syndrome.
    International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity, 2003, Volume: 27, Issue:7

    Topics: Anticholesteremic Agents; Apolipoprotein B-100; Apolipoproteins B; Atorvastatin; Cholesterol; Cholesterol, VLDL; Double-Blind Method; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Metabolic Syndrome; Middle Aged; Phytosterols; Pyrroles

2003

Other Studies

2 other study(ies) available for campesterol and Metabolic Syndrome

ArticleYear
Plasma markers of cholesterol homeostasis in metabolic syndrome subjects with or without type-2 diabetes.
    Diabetes research and clinical practice, 2009, Volume: 85, Issue:3

    Topics: Adiponectin; Apolipoprotein A-I; Apolipoproteins; Biomarkers; Blood Glucose; Blood Pressure; Cholesterol; Diabetes Mellitus, Type 2; Female; Gas Chromatography-Mass Spectrometry; Homeostasis; Humans; Male; Metabolic Syndrome; Middle Aged; Obesity; Phytosterols; Reference Values; Triglycerides

2009
Plasma markers of cholesterol homeostasis and apolipoprotein B-100 kinetics in the metabolic syndrome.
    Obesity research, 2003, Volume: 11, Issue:4

    Topics: Adult; Apolipoprotein B-100; Apolipoproteins B; Biomarkers; Cholesterol; Homeostasis; Humans; Kinetics; Lipoproteins; Lipoproteins, IDL; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Metabolic Syndrome; Middle Aged; Phytosterols

2003